Interestingly, it was demonstrated that IL-6 blockade significantly inhibited lung cancer promotion, tumour cell-intrinsic STAT3 activation, tumour cell proliferation, and angiogenesis markers [139]. This evidence concerns the gene STAT3 and lung carcinoma.